METASTATIC ALVEOLAR SOFT PART SARCOMA
Clinical trials for METASTATIC ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer trial tests 'Less is More' approach to powerful drug
Disease control Recruiting nowThis study is testing a new method for giving the cancer drug atezolizumab. Researchers want to see if they can use lower doses, given less often, by carefully monitoring drug levels in a patient's blood. The goal is to see if this personalized approach can still control the canc…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for rare cancer: Two-Drug attack on tough sarcoma
Disease control Recruiting nowThis study is testing if a combination of two drugs, atezolizumab and selinexor, can shrink tumors in patients with advanced alveolar soft part sarcoma, a rare and difficult-to-treat cancer. The trial is for patients whose cancer has continued to grow despite prior immunotherapy.…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC